ERCC1 and cancer: Successful sensitization of cancer cells to cyclophosphamide would imply that 6 inhibited cellular ICL as well as NER, lending credence to the notion that compound 6 was indeed inhibiting NER by inhibiting the endonuclease activity of ERCC1-XPF and not via inhibition of another protein involved in NER.